118 related articles for article (PubMed ID: 9737940)
1. Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo.
Nordt TK; Sawa H; Fujii S; Bode C; Sobel BE
J Mol Cell Cardiol; 1998 Aug; 30(8):1535-43. PubMed ID: 9737940
[TBL] [Abstract][Full Text] [Related]
2. Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin.
Nordt TK; Bode C; Sobel BE
Diabetologia; 2001 Sep; 44(9):1121-4. PubMed ID: 11596666
[TBL] [Abstract][Full Text] [Related]
3. Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.
Nordt TK; Sawa H; Fujii S; Sobel BE
Circulation; 1995 Feb; 91(3):764-70. PubMed ID: 7828304
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
6. Type 1 plasminogen activator inhibitor is not an acute phase reactant in rats. Lack of IL-6- and hepatocyte-dependent synthesis.
Podor TJ; Hirsh J; Gelehrter TD; Zeheb R; Torry D; Guigoz Y; Sierra F; Gauldie J
J Immunol; 1993 Jan; 150(1):225-35. PubMed ID: 7678029
[TBL] [Abstract][Full Text] [Related]
7. C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo.
Kairuz EM; Barber MN; Anderson CR; Kanagasundaram M; Drummond GR; Woods RL
Cardiovasc Res; 2005 Jun; 66(3):574-82. PubMed ID: 15914122
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls.
Chomiki N; Henry M; Alessi MC; Anfosso F; Juhan-Vague I
Thromb Haemost; 1994 Jul; 72(1):44-53. PubMed ID: 7974374
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3'-untranslated region of the PAI-1 gene and its pharmacologic implications.
Miyagawa R; Asakura T; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
Coron Artery Dis; 2010 May; 21(3):144-50. PubMed ID: 20299979
[TBL] [Abstract][Full Text] [Related]
10. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
[TBL] [Abstract][Full Text] [Related]
11. Expression of plasminogen activator inhibitor type I in genotyped human endothelial cell cultures: genotype-specific regulation by insulin.
Grenett HE; Benza RL; Li XN; Aikens ML; Grammer JR; Brown SL; Booyse FM
Thromb Haemost; 1999 Nov; 82(5):1504-9. PubMed ID: 10595645
[TBL] [Abstract][Full Text] [Related]
12. Determinants of plasminogen activator inhibitor-1 activity in survivors of myocardial infarction.
Gray RP; Mohamed-Ali V; Patterson DL; Yudkin JS
Thromb Haemost; 1995 Feb; 73(2):261-7. PubMed ID: 7792741
[TBL] [Abstract][Full Text] [Related]
13. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver.
Dimova EY; Kietzmann T
Thromb Haemost; 2008 Dec; 100(6):992-1006. PubMed ID: 19132222
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozil.
Fujii S; Sawa H; Sobel BE
Thromb Haemost; 1993 Oct; 70(4):642-7. PubMed ID: 7509512
[TBL] [Abstract][Full Text] [Related]
15. In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element.
Dichtl W; Ares MP; Stollenwerk M; Giachelli CM; Scatena M; Hamsten A; Eriksson P; Nilsson J
Thromb Haemost; 2000 Oct; 84(4):706-11. PubMed ID: 11057874
[TBL] [Abstract][Full Text] [Related]
16. A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model.
Witkowski P; Seki T; Xiang G; Martens T; Sondermeijer H; See F; Bhagat G; Schuster M; Hardy MA; Itescu S
J Cardiovasc Pharmacol; 2007 Dec; 50(6):633-40. PubMed ID: 18091579
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.
Nordt TK; Schneider DJ; Sobel BE
Circulation; 1994 Jan; 89(1):321-30. PubMed ID: 8281664
[TBL] [Abstract][Full Text] [Related]
18. [A multicomparmental and multifactorial model of production of plasminogen activator inhibitor (PAI-1). I. Experimental studies].
Galajda P; Kubisz P; Mokán M
Vnitr Lek; 1998 Dec; 44(12):718-21. PubMed ID: 10422516
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
20. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
